A Phase 4 interventional study of Oxytocin in Abortion, Induced, Labor Stage, Third/Drug Effects and Pregnancy Trimester, Second, sponsored by Ataturk University. Completed at 1 site in Turkey. Open to female participants aged 17 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-02-28.
Sponsored by Ataturk University · Phase 4, Interventional, and Treatment
This study compares oxytocin infusion to spontaneous follow-up for third-stage of labor at induced mid-trimester abortions. Patients will be randomized to oxytocin infusion or observation with no pharmacologic intervention. Primary outcome of the study is complete abortion rate within two hours of fetal delivery.
Ataturk University is the lead sponsor of 442 studies on the registry; 121 are open to participants now.
Counted across the registry records on this site, refreshed daily.
-Women who had mid-trimester termination of pregnancy between 13-24 gestational weeks
Exclusion Criteria:
Drug: Oxytocin
20 IU oxytocin in 500 ml normal saline will be infused 100 ml/h i.v. after fetus is delivered
Also known as: Synpitan, Pitocin
Complete abortion rate
expulsion of placenta completely without an instrumental assistance within two hours after delivery of fetus
Time frame: within 5 minute after placenta delivered
Blood loss estimated by gravimetric method
blood loss will be estimated by gravimetric method
Time frame: within 10 minutes after delivery of placenta
Transfusion rate
number of packed red cell units transfused
Time frame: Within 7 days of hospitalization
Change in hemoglobin measured by difference in hemoglobin before and 24-hour after abortion
Difference in hemoglobin before and 24-hour after abortion
Time frame: 24 hours after delivery of placenta
Placenta delivery time measured by time elapsed until the delivery of the placenta from the delivery of foetus
The time elapsed until the delivery of the placenta from the delivery of foetus
Time frame: 5 minute after delivery of placenta
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ataturk University